TriSalus Life Sciences, Inc.TLSINASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank76
3Y CAGR-17.4%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-17.4%/yr
Quarterly compound
Percentile
P76
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 35.67% |
| Q3 2025 | 45.69% |
| Q2 2025 | -37.58% |
| Q1 2025 | 8.75% |
| Q4 2024 | 47.74% |
| Q3 2024 | 18.29% |
| Q2 2024 | -23.31% |
| Q1 2024 | -14.49% |
| Q4 2023 | 56.28% |
| Q3 2023 | -135.70% |
| Q2 2023 | 12.39% |
| Q1 2023 | -23.25% |
| Q4 2022 | 63.22% |
| Q3 2022 | -183.66% |
| Q2 2022 | 25.16% |
| Q1 2022 | -1513.99% |
| Q4 2021 | -86.48% |
| Q3 2021 | 24.90% |
| Q2 2021 | -136.20% |
| Q1 2021 | 69.62% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |